Litigation Details for ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL INC. (D.N.J. 2017)
✉ Email this page to a colleague
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL INC. (D.N.J. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-10-31 |
| Court | District Court, D. New Jersey | Date Terminated | 2021-09-14 |
| Cause | 35:271 Patent Infringement | Assigned To | Esther Salas |
| Jury Demand | None | Referred To | Michael A. Hammer |
| Patents | 8,481,598; 8,865,937; RE43,879 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL INC. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-10-31 | 1 | United States Patent Nos. 8,481,598 (“the ’598 patent”), 8,865,937 (“the ’937 patent”), and RE43,879… infringed United States Patent Nos. 8,481,598, 8,865,937, and RE43,879 by submitting ANDA…products before United States Patent Nos. 8,481,598 and RE43,879 expire, would …expiration date of United States Patent Nos. 8,481,598, 8,865,937, and RE43,879, including any …Page 16 of 19 PageID: 16 States Patent Nos. 8,481,598, 8,865,937, and RE43,879 expire, including | External link to document | |
| 2021-06-08 | 455 | Opinion | the three asserted patents: United States Patents No. 8,481,598 (the “’598 Patent”) and No. RE43, 879… Legal Standard A patent claim is that “portion of the patent document that defines the scope…of levomilnacipran.” ’598 Patent at 11:38–39 (emphasis added). The patent defines the terms “effective…Rather, a POSA reading the patent as a whole would understand that the patent is directed at administering…which is how the ’598 Patent refers to the dosage amounts. See, e.g., ’598 Patent at 3:11–13, 3:17–19, | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
